Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 9 | 2022 | 244 | 1.140 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2022 | 220 | 0.790 |
Why?
|
| Endovascular Procedures | 8 | 2022 | 617 | 0.780 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2022 | 280 | 0.730 |
Why?
|
| Ischemia | 6 | 2025 | 198 | 0.720 |
Why?
|
| Peripheral Arterial Disease | 5 | 2025 | 163 | 0.720 |
Why?
|
| Lost to Follow-Up | 2 | 2019 | 7 | 0.660 |
Why?
|
| Lower Extremity | 5 | 2023 | 161 | 0.590 |
Why?
|
| Postoperative Care | 1 | 2016 | 124 | 0.490 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 140 | 0.430 |
Why?
|
| Vascular Grafting | 3 | 2025 | 37 | 0.380 |
Why?
|
| Surgeons | 3 | 2020 | 184 | 0.360 |
Why?
|
| Endarterectomy, Carotid | 3 | 2022 | 79 | 0.340 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2021 | 47 | 0.320 |
Why?
|
| Time Factors | 11 | 2025 | 3782 | 0.300 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 99 | 0.300 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2021 | 109 | 0.300 |
Why?
|
| Relative Value Scales | 2 | 2020 | 14 | 0.290 |
Why?
|
| Intermittent Claudication | 2 | 2019 | 53 | 0.280 |
Why?
|
| Fee-for-Service Plans | 2 | 2020 | 70 | 0.280 |
Why?
|
| Risk Factors | 12 | 2025 | 5437 | 0.280 |
Why?
|
| Treatment Outcome | 13 | 2025 | 5824 | 0.280 |
Why?
|
| Thrombosis | 2 | 2021 | 204 | 0.270 |
Why?
|
| Retrospective Studies | 16 | 2023 | 6901 | 0.270 |
Why?
|
| Health Services Needs and Demand | 2 | 2020 | 224 | 0.260 |
Why?
|
| Saphenous Vein | 2 | 2025 | 52 | 0.250 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2022 | 215 | 0.250 |
Why?
|
| Aorta, Abdominal | 2 | 2022 | 56 | 0.220 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 5621 | 0.210 |
Why?
|
| Registries | 5 | 2021 | 904 | 0.210 |
Why?
|
| Aged | 14 | 2025 | 14965 | 0.210 |
Why?
|
| Aortography | 2 | 2022 | 57 | 0.200 |
Why?
|
| Risk Assessment | 7 | 2025 | 2098 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2022 | 52 | 0.180 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Medicare | 3 | 2022 | 617 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2021 | 820 | 0.180 |
Why?
|
| Humans | 29 | 2025 | 65676 | 0.180 |
Why?
|
| Walking | 1 | 2023 | 241 | 0.170 |
Why?
|
| Health Facilities | 1 | 2020 | 45 | 0.170 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2020 | 43 | 0.160 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 55 | 0.160 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 18 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 49 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 115 | 0.160 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 58 | 0.160 |
Why?
|
| Documentation | 2 | 2018 | 132 | 0.160 |
Why?
|
| Data Accuracy | 2 | 2018 | 31 | 0.160 |
Why?
|
| Prosthesis Design | 4 | 2022 | 230 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 84 | 0.150 |
Why?
|
| Celiac Artery | 1 | 2019 | 13 | 0.150 |
Why?
|
| Popliteal Artery | 1 | 2019 | 24 | 0.150 |
Why?
|
| Clinical Coding | 2 | 2018 | 46 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 105 | 0.150 |
Why?
|
| Aneurysm | 1 | 2019 | 58 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 82 | 0.150 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 354 | 0.150 |
Why?
|
| New England | 2 | 2016 | 271 | 0.140 |
Why?
|
| Vascular Patency | 4 | 2021 | 134 | 0.140 |
Why?
|
| Atherectomy | 1 | 2018 | 8 | 0.140 |
Why?
|
| General Surgery | 1 | 2021 | 215 | 0.140 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 416 | 0.140 |
Why?
|
| Forms and Records Control | 1 | 2018 | 15 | 0.140 |
Why?
|
| Male | 13 | 2025 | 31137 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2008 | 46 | 0.140 |
Why?
|
| Middle Aged | 9 | 2025 | 18314 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2018 | 87 | 0.140 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 147 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 143 | 0.140 |
Why?
|
| Medical Records | 1 | 2018 | 140 | 0.140 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 136 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 213 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 227 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 936 | 0.130 |
Why?
|
| Female | 13 | 2025 | 34182 | 0.130 |
Why?
|
| Physician's Role | 1 | 2018 | 125 | 0.130 |
Why?
|
| United States | 8 | 2025 | 8149 | 0.130 |
Why?
|
| Physicians | 1 | 2022 | 491 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2018 | 204 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 555 | 0.130 |
Why?
|
| Endoleak | 3 | 2021 | 39 | 0.120 |
Why?
|
| Databases, Factual | 4 | 2021 | 877 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2018 | 716 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2016 | 145 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 761 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 1706 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2018 | 470 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1281 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2016 | 343 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 1118 | 0.090 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2012 | 1 | 0.090 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2012 | 5 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2010 | 1043 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 119 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2012 | 128 | 0.080 |
Why?
|
| Workload | 2 | 2021 | 128 | 0.080 |
Why?
|
| Indazoles | 1 | 2010 | 18 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2010 | 14 | 0.080 |
Why?
|
| Sarcoma, Ewing | 1 | 2010 | 15 | 0.080 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 31 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 34 | 0.080 |
Why?
|
| Limb Salvage | 2 | 2025 | 65 | 0.080 |
Why?
|
| Reoperation | 2 | 2025 | 300 | 0.070 |
Why?
|
| Leukemia, Myeloid | 1 | 2008 | 36 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 129 | 0.070 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2008 | 52 | 0.070 |
Why?
|
| Critical Illness | 2 | 2025 | 332 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2022 | 3373 | 0.070 |
Why?
|
| Health Care Surveys | 2 | 2020 | 293 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2021 | 1331 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 207 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2021 | 60 | 0.070 |
Why?
|
| Leukemia | 1 | 2007 | 62 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2007 | 125 | 0.070 |
Why?
|
| Stents | 2 | 2021 | 499 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 427 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1578 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 798 | 0.060 |
Why?
|
| Comorbidity | 2 | 2018 | 1122 | 0.060 |
Why?
|
| Acute Disease | 2 | 2019 | 681 | 0.050 |
Why?
|
| Survival Rate | 2 | 2021 | 863 | 0.050 |
Why?
|
| Massachusetts | 2 | 2019 | 2149 | 0.050 |
Why?
|
| Angioplasty | 1 | 2022 | 53 | 0.050 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2022 | 44 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Iliac Artery | 1 | 2021 | 43 | 0.040 |
Why?
|
| Renal Artery | 1 | 2021 | 36 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 76 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 93 | 0.040 |
Why?
|
| Fasciotomy | 1 | 2019 | 11 | 0.040 |
Why?
|
| Ligation | 1 | 2019 | 39 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 168 | 0.040 |
Why?
|
| Retreatment | 1 | 2019 | 44 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 71 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 112 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 215 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2021 | 249 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 186 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 42 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 282 | 0.030 |
Why?
|
| Certification | 1 | 2018 | 58 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2021 | 520 | 0.030 |
Why?
|
| Patient Admission | 1 | 2018 | 200 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 736 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 213 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 229 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 498 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 451 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 690 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 832 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 315 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 2071 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 404 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2706 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2012 | 65 | 0.020 |
Why?
|
| Stroke | 1 | 2021 | 1208 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2012 | 42 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 742 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 99 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 208 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 466 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 328 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 531 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2008 | 15 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 25 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 59 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 45 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 528 | 0.020 |
Why?
|
| Cyclin A | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 164 | 0.020 |
Why?
|
| Histones | 1 | 2008 | 498 | 0.010 |
Why?
|
| Mice | 2 | 2010 | 11193 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 683 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 642 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1686 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17481 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4860 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1634 | 0.010 |
Why?
|
| Animals | 2 | 2010 | 21500 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3471 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3152 | 0.010 |
Why?
|